Nasdaq tells KaloBios its bankruptcy filing is further grounds for delisting
December 31, 2015 at 12:12 PM EST
Nasdaq says there are now several reasons to delist the biotech’s shares.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.